Physician profile
Vonda J Capper
NPI 1861500910
$1,771.77
in general payments reported to CMS, 2019-2025
9 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.11 · 2020: $53.41 · 2021: $124 · 2022: $53.87 · 2023: $1,392 · 2024: $14.91 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $952 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $952.42 |
| Food and Beverage | $573.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,561.04 | 2021-2025 | Precision7, Precision 1, Total30 |
| Dompe US, INC. | $56.44 | 2021 | |
| Aerie Pharmaceuticals, INC. | $32.39 | 2020-2021 | |
| Allergan, INC. | $28.08 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $24.53 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.61 | 2020 | |
| Bausch & Lomb Americas INC. | $18.11 | 2023 | Lotemax Sm, Vyzulta, Prolensa |
| Sun Pharmaceutical Industries INC. | $15.11 | 2019 | |
| The Cameron-Ehlen Group, INC. | $13.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vonda Capper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.